Profit after tax as a percentage of net worth for public limited companies in the pharmaceutical industry for the 2016-17 fiscal year

Annual · percent · 2014–2016 · Published by India — Reserve Bank of India

Latest · 2016

13.3%

down −4.1 pts vs 2015

High since 2014
17.4% · 2015
Low since 2014
11.4% · 2014

percent

Use this series in your AI

Use FactIQ to chart rbi::rbi|00fc67e34ae3222a over the last ten years, with its latest value and the change over the past year.

Paste into an AI model with FactIQ connected. How to connect

About this series

This series represents the financial ratio of profit after tax to net worth for non-government non-financial public limited companies specifically within the pharmaceutical industry. The data is part of a historical reference for the 2016-17 fiscal year and is sourced from the Reserve Bank of India's Statement 12, which tracks select financial ratios across various industries. (Footnote: *=actual ratio; ^=average assets; **=profit-making-company subset; @=two-year-difference derived metric; # and -=missing token)

Series ID
rbi::rbi|00fc67e34ae3222a
Frequency
Annual
Units
percent
Coverage
2014 – 2016
Profit after tax as a percentage of net worth for public limited companies in the pharmaceutical industry for the 2016-17 fiscal year: 13.3% for 2016 · FactIQ